Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Fulminant Immune Checkpoint Inhibitor-Related Encephalitis (ICI-Encephalitis) Presenting Rapidly After First Infusion of Nivolumab: A Case Report.
Journal: Case reports in oncological medicine
Published: November 12, 2025
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 01, 2024
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: June 26, 2023
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: August 02, 2022
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
Journal: JCO precision oncology
Published: December 18, 2020
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Journal: American journal of hematology
Published: August 31, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026